TipRanks
SI-Bone Inc (DE:2K3)
FRANKFURT:2K3
Germany Market

SI-Bone (2K3) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

2K3 Analyst Ratings

Strong Buy
7Ratings
Strong Buy
7 Buy
0 Hold
0 Sell
Based on 7 analysts giving stock ratings to
SI-Bone
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

2K3 Stock 12 Month Forecast

Average Price Target

€22.16
▲(36.80% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for SI-Bone in the last 3 months. The average price target is €22.16 with a high forecast of €24.09 and a low forecast of €17.85. The average price target represents a 36.80% change from the last price of €16.20.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"9":"€9","13":"€13","17":"€17","21":"€21","25":"€25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":24.09490179,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€24.09</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":22.16136028833333,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€22.16</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":17.8480754,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€17.85</span>\n  </div></div>","useHTML":true}}],"tickPositions":[9,13,17,21,25],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.4,16.991915522307693,17.583831044615383,18.175746566923078,18.767662089230768,19.359577611538462,19.951493133846153,20.543408656153847,21.135324178461538,21.727239700769232,22.319155223076923,22.911070745384617,23.502986267692307,{"y":24.09490179,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.4,16.843181560641025,17.28636312128205,17.729544681923073,18.1727262425641,18.615907803205126,19.05908936384615,19.502270924487178,19.945452485128204,20.38863404576923,20.831815606410252,21.27499716705128,21.718178727692305,{"y":22.16136028833333,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.4,16.511390415384614,16.62278083076923,16.734171246153846,16.84556166153846,16.956952076923077,17.068342492307693,17.179732907692305,17.29112332307692,17.402513738461536,17.513904153846152,17.625294569230768,17.736684984615383,{"y":17.8480754,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":12.3,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.3,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.7,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.7,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.7,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.8,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.1,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.8,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.4,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.4,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€24.09Average Price Target€22.16Lowest Price Target€17.85
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Canaccord Genuity Analyst forecast on DE:2K3
Canaccord Genuity
Canaccord Genuity
€24.09
Buy
48.73%
Upside
Reiterated
10/14/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Truist Financial Analyst forecast on DE:2K3
Truist Financial
Truist Financial
€20.53→€22.31
Buy
37.72%
Upside
Reiterated
10/14/26
SI-Bone price target raised to $25 from $23 at TruistSI-Bone price target raised to $25 from $23 at Truist
TD Cowen
€16.06→€17.85
Buy
10.17%
Upside
Assigned
08/04/26
Analysts Are Bullish on These Healthcare Stocks: Stoke Therapeutics (STOK), Fortrea Holdings Inc. (FTRE)
Bank of America Securities Analyst forecast on DE:2K3
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
08/04/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Needham
€24.09
Buy
48.73%
Upside
Reiterated
08/04/26
Needham Keeps SI-Bone on Conviction List With Buy Rating and Unchanged $27 Price Target After Strong Q2 and Raised 2026 Guidance
UBS
€21.42→€22.31
Buy
37.72%
Upside
Reiterated
08/04/26
SI-Bone price target raised to $25 from $24 at UBSSI-Bone price target raised to $25 from $24 at UBS
Piper Sandler Analyst forecast on DE:2K3
Piper Sandler
Piper Sandler
€22.31
Buy
37.72%
Upside
Reiterated
08/04/26
SI-Bone (SIBN) Receives a Buy from Piper Sandler
Jefferies Analyst forecast on DE:2K3
Jefferies
Jefferies
€24.99
Buy
54.24%
Upside
Reiterated
01/09/26
Jefferies Remains a Buy on SI-Bone (SIBN)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Canaccord Genuity Analyst forecast on DE:2K3
Canaccord Genuity
Canaccord Genuity
€24.09
Buy
48.73%
Upside
Reiterated
10/14/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Truist Financial Analyst forecast on DE:2K3
Truist Financial
Truist Financial
€20.53→€22.31
Buy
37.72%
Upside
Reiterated
10/14/26
SI-Bone price target raised to $25 from $23 at TruistSI-Bone price target raised to $25 from $23 at Truist
TD Cowen
€16.06→€17.85
Buy
10.17%
Upside
Assigned
08/04/26
Analysts Are Bullish on These Healthcare Stocks: Stoke Therapeutics (STOK), Fortrea Holdings Inc. (FTRE)
Bank of America Securities Analyst forecast on DE:2K3
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
08/04/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Needham
€24.09
Buy
48.73%
Upside
Reiterated
08/04/26
Needham Keeps SI-Bone on Conviction List With Buy Rating and Unchanged $27 Price Target After Strong Q2 and Raised 2026 Guidance
UBS
€21.42→€22.31
Buy
37.72%
Upside
Reiterated
08/04/26
SI-Bone price target raised to $25 from $24 at UBSSI-Bone price target raised to $25 from $24 at UBS
Piper Sandler Analyst forecast on DE:2K3
Piper Sandler
Piper Sandler
€22.31
Buy
37.72%
Upside
Reiterated
08/04/26
SI-Bone (SIBN) Receives a Buy from Piper Sandler
Jefferies Analyst forecast on DE:2K3
Jefferies
Jefferies
€24.99
Buy
54.24%
Upside
Reiterated
01/09/26
Jefferies Remains a Buy on SI-Bone (SIBN)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
MDWDMediwound
IMUXImmunic
RZLTRezolute
DFTXDefinium Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering SI-Bone

3 Months
Richard NewitterTruist Financial
Success Rate
11/18 ratings generated profit
61%
Average Return
+8.31%
Copying Richard Newitter's trades and holding each position for 3 Months would result in 61.11% of your transactions generating a profit, with an average return of +8.31% per trade.
1 Year
Richard NewitterTruist Financial
Success Rate
15/18 ratings generated profit
83%
Average Return
+19.78%
Copying Richard Newitter's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +19.78% per trade.
2 Years
Richard NewitterTruist Financial
Success Rate
17/18 ratings generated profit
94%
Average Return
+36.56%
Copying Richard Newitter's trades and holding each position for 2 Years would result in 94.44% of your transactions generating a profit, with an average return of +36.56% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

2K3 Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
5
4
1
0
0
Buy
4
5
9
11
11
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
9
9
10
11
11
In the current month, 2K3 has received 11 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 2K3 average Analyst price target in the past 3 months is 22.16.
Each month's total comprises the sum of three months' worth of ratings.

2K3 Financial Forecast

2K3 Earnings Forecast

Next quarter’s earnings estimate for 2K3 is -€0.11 with a range of -€0.16 to -€0.07. The previous quarter’s EPS was -€0.08. 2K3 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 2K3 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 2K3 is -€0.11 with a range of -€0.16 to -€0.07. The previous quarter’s EPS was -€0.08. 2K3 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 2K3 has Performed in-line its overall industry.

2K3 Sales Forecast

Next quarter’s sales forecast for 2K3 is €49.36M with a range of €49.17M to €49.72M. The previous quarter’s sales results were €49.98M. 2K3 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 2K3 has Performed in-line its overall industry.
Next quarter’s sales forecast for 2K3 is €49.36M with a range of €49.17M to €49.72M. The previous quarter’s sales results were €49.98M. 2K3 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 2K3 has Performed in-line its overall industry.

2K3 Stock Forecast FAQ

What is DE:2K3’s average 12-month price target, according to analysts?
Based on analyst ratings, SI-Bone Inc’s 12-month average price target is 22.16.
    What is DE:2K3’s upside potential, based on the analysts’ average price target?
    SI-Bone Inc has 36.80% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is SI-Bone Inc a Buy, Sell or Hold?
          SI-Bone Inc has a consensus rating of Strong Buy, which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.
            What is SI-Bone Inc’s share price target?
            The average share price target for SI-Bone Inc is 22.16. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €24.09 ,and the lowest forecast is €17.85. The average share price target represents 36.80% Increase from the current price of €16.2.
              What do analysts say about SI-Bone Inc?
              SI-Bone Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of SI-Bone Inc?
                To buy shares of DE:2K3, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.